Clinion is a global clinical technology company that offers AI-enabled eClinical solutions for managing clinical trials. Their flagship product is the Clinion EDC (Electronic Data Capture) platform, which is part of a broader suite of integrated clinical trial management tools. Founded in 2010 and headquartered in Austin, Texas, Clinion has positioned itself as an innovator in using AI and automation to streamline clinical trial processes.
Clinion was founded in 2010 by a team with experience in clinical research and technology. The company has grown steadily over the years, expanding its product offerings and global reach. Clinion now serves over 500 customers in 27 countries, with a particularly strong presence in the Nordic region.
Clinion's core product is its EDC platform, which offers:
Advanced data extraction and reporting capabilities
Other products in Clinion's eClinical suite include:
Clinion continuously updates its platform with new AI-driven features.
Recent additions include:
Clinion emphasizes innovation, customer-centricity, and a commitment to accelerating clinical trials through technology. The company values transparency, efficiency, and continuous improvement in its products and services.
Clinion serves a diverse range of users in the clinical research industry, including:
The company has received positive reviews from users, with particular praise for its ease of use, comprehensive features, and the efficiency gains provided by its AI-driven tools. Clinion has built a strong community of users who rely on its platform for managing clinical trials efficiently.
